Fund
Andreessen Horowitz
Page built from the operations logged, not from a written profile. It says nothing about the fund's activity outside the scope of Bolus, which is health venture capital in Europe and the United States.
- Operations logged
- 3
- Lead
- 1
- New entries
- 1
- Follow ons
- 1
- Latest operation
- 24 September 2026
- Sectors
- Biotech, Health software
Operations
| Date | Company | Stage | Amount | Role |
|---|---|---|---|---|
| 24 Sept | United States, Biotech | Series C | 75 M$ | Existing investor |
| 16 Sept | United States, Health software | Seed | 9 M$ | Lead |
| 15 Sept | United States | Undisclosed | 108 M$ | Participant |
Co investors 29 funds crossed
- Avid Ventures 2 operations
- Eli Lilly and Company 2 operations
- Index Ventures 2 operations
- 8VC 1 operation
- ADP Ventures 1 operation
- Alexandria Venture Investments 1 operation
- Amgen Ventures 1 operation
- Asymmetric Capital 1 operation
- Box Group 1 operation
- Catalio Capital Management 1 operation
- DFJ Growth 1 operation
- Discovery Ventures 1 operation
- General Catalyst 1 operation
- GRIDS Capital 1 operation
- Intermountain Ventures 1 operation
- Layout Ventures 1 operation
- LG Technology Ventures 1 operation
- Merck Global Health Innovation Fund 1 operation
- Paychex 1 operation
- Premji Invest 1 operation
- Quadrille Capital 1 operation
- QuantumLight 1 operation
- Quiet Capital 1 operation
- S32 1 operation
- Scale Venture Partners 1 operation
- SemperVirens 1 operation
- Sigmas Group 1 operation
- SV Angel 1 operation
- The General Partnership 1 operation
Funds that appeared in the same rounds, in any capacity. Geographies logged: United States.